IRMD - IRadimed Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5222.54M
Enterprise Value 3179.25M
Trailing P/E 23.94
Forward P/E 114.94
PEG Ratio (5 yr expected) 11.24
Price/Sales (ttm)5.78
Price/Book (mrq)3.96
Enterprise Value/Revenue 34.65
Enterprise Value/EBITDA 618.12

Trading Information

Stock Price History

Beta (5Y Monthly) 1.67
52-Week Change 3-32.65%
S&P500 52-Week Change 3-11.36%
52 Week High 329.80
52 Week Low 314.41
50-Day Moving Average 322.68
200-Day Moving Average 323.48

Share Statistics

Avg Vol (3 month) 350.71k
Avg Vol (10 day) 356.8k
Shares Outstanding 511.48M
Float 5.94M
% Held by Insiders 150.90%
% Held by Institutions 133.22%
Shares Short (Mar 12, 2020) 4435.9k
Short Ratio (Mar 12, 2020) 49.45
Short % of Float (Mar 12, 2020) 48.46%
Short % of Shares Outstanding (Mar 12, 2020) 43.66%
Shares Short (prior month Feb 13, 2020) 4456.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 25.00%
Operating Margin (ttm)22.45%

Management Effectiveness

Return on Assets (ttm)9.39%
Return on Equity (ttm)19.76%

Income Statement

Revenue (ttm)38.52M
Revenue Per Share (ttm)3.41
Quarterly Revenue Growth (yoy)30.60%
Gross Profit (ttm)29.7M
EBITDA 9.89M
Net Income Avi to Common (ttm)9.63M
Diluted EPS (ttm)0.78
Quarterly Earnings Growth (yoy)89.90%

Balance Sheet

Total Cash (mrq)46.25M
Total Cash Per Share (mrq)3.88
Total Debt (mrq)2.96M
Total Debt/Equity (mrq)5.32
Current Ratio (mrq)10.06
Book Value Per Share (mrq)4.72

Cash Flow Statement

Operating Cash Flow (ttm)10.23M
Levered Free Cash Flow (ttm)6.4M